Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gundert-Remy

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Cerebrospinal fluid patency of ethambutol]U Gundert-Remy, E Weber, M Klett
European Journal of Clinical Pharmacology|August 1, 1973
Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serumU Gundert-Remy, M Klett, E Weber
Archives of Toxicology|May 12, 2019
Letter to the Editor : Comment on 'Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine' by Ning et al., Arch Toxicol doi: https://doi.org/10.1007/s00204-019-02397-7H Mielke, F Partosch, U Gundert-Remy
British Journal of Clinical Pharmacology|November 1, 1986
Plasma concentrations of theophylline and its metabolites in a theophylline intoxicated child--reevaluation of published Km-valuesU Gundert-Remy, B Krüdewagen, R Hildebrandt
Toxicology Letters|May 17, 2011
The contribution of dermal exposure to the internal exposure of bisphenol A in manH Mielke, F Partosch, U Gundert-Remy
British Journal of Clinical Pharmacology|December 1, 1979
Determination of the ureidopenicillins azlocillin, mezlocillin and bay K 4999 in plasma by high performance liquid chromatographyU Gundert-Remy, J X De Vries
Arzneimittel-Forschung|January 1, 1978
3H-Cymarol in man. Excretion pathways and serum protein bindingU Gundert-Remy, E Weber, W Rabl
Die Medizinische Welt|September 2, 1983
[Biopharmaceutical, pharmacokinetic and pharmacodynamic aspects of glibenclamide compounds]H Möller, S L Ali, U Gundert-Remy
Journal of Pharmaceutical Sciences|July 1, 1985
Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. I: PharmacokineticsP H Hinderling, U Gundert-Remy, O Schmidlin
European Journal of Clinical Pharmacology|January 17, 2002
In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting reportO Pelkonen, A R Boobis, U Gundert-Remy, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Cerebrospinal fluid patency of ethambutol]U Gundert-Remy, E Weber, M Klett
European Journal of Clinical Pharmacology|August 1, 1973
Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serumU Gundert-Remy, M Klett, E Weber
Archives of Toxicology|May 12, 2019
Letter to the Editor : Comment on 'Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine' by Ning et al., Arch Toxicol doi: https://doi.org/10.1007/s00204-019-02397-7H Mielke, F Partosch, U Gundert-Remy
British Journal of Clinical Pharmacology|November 1, 1986
Plasma concentrations of theophylline and its metabolites in a theophylline intoxicated child--reevaluation of published Km-valuesU Gundert-Remy, B Krüdewagen, R Hildebrandt
Toxicology Letters|May 17, 2011
The contribution of dermal exposure to the internal exposure of bisphenol A in manH Mielke, F Partosch, U Gundert-Remy
British Journal of Clinical Pharmacology|December 1, 1979
Determination of the ureidopenicillins azlocillin, mezlocillin and bay K 4999 in plasma by high performance liquid chromatographyU Gundert-Remy, J X De Vries
Arzneimittel-Forschung|January 1, 1978
3H-Cymarol in man. Excretion pathways and serum protein bindingU Gundert-Remy, E Weber, W Rabl
Die Medizinische Welt|September 2, 1983
[Biopharmaceutical, pharmacokinetic and pharmacodynamic aspects of glibenclamide compounds]H Möller, S L Ali, U Gundert-Remy
Journal of Pharmaceutical Sciences|July 1, 1985
Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. I: PharmacokineticsP H Hinderling, U Gundert-Remy, O Schmidlin
European Journal of Clinical Pharmacology|January 17, 2002
In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting reportO Pelkonen, A R Boobis, U Gundert-Remy, et al.
Pageof 13